Business Description
Amarin Corporation is an Ireland-based company focused on developing and selling heart health medicines across the United States, Europe, and other markets. Its main product, VASCEPA, is a prescription omega-3 supplement that helps lower dangerously high fat levels in the blood when diet alone is not enough. The company distributes its medicines through wholesale and pharmacy channels and works with Japan's Mochida Pharmaceutical to expand the medical applications of VASCEPA's key ingredient. Founded in 1989, Amarin has operated under its current name since 1999.
